Skip to content

Clinical trials

Lymphoma, B-Cell, Marginal Zone trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Country / region: United Kingdom Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20061
20072
20091
20111
20133
20141
20162
20173
20182
20194
20201
20215
20222
20233
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting8
Recruiting6
Unknown status6
Terminated5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences4
AbbVie2
BeOne Medicines2
European Organisation for Research and Treatment of Cancer - EORTC2
Incyte Corporation2
International Extranodal Lymphoma Study Group (IELSG)2
MEI Pharma, Inc.2
Regeneron Pharmaceuticals2
AstraZeneca1
BeiGene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone43
Lymphoma, Follicular33
Leukemia, Lymphocytic, Chronic, B-Cell22
Lymphoma, Mantle-Cell22
Lymphoma, Non-Hodgkin18
Lymphoma, Large B-Cell, Diffuse17
Waldenstrom Macroglobulinemia16
Lymphoma13
Lymphoma, B-Cell8
Recurrence8

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.